H.R.1902 - Protecting Consumer Access to Generic Drugs Act of 2007
To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. view all titles (2)
All Bill Titles
- Short: Protecting Consumer Access to Generic Drugs Act of 2007 as introduced.
- Official: To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
Bill's Views
- Today: 2
- Past Seven Days: 12
- All-Time: 1,516
|
|
|
|
|
|
|
|
Official Summary
4/17/2007--Introduced.Protecting Consumer Access to Generic Drugs Act of 2007 - Prohibits, as an unfair and deceptive act or practice and an unfair method of competition in or affecting interstate commerce, any person from being a party to any agreement resolving or settling a patent infriOfficial Summary
4/17/2007--Introduced.Protecting Consumer Access to Generic Drugs Act of 2007 - Prohibits, as an unfair and deceptive act or practice and an unfair method of competition in or affecting interstate commerce, any person from being a party to any agreement resolving or settling a patent infringement claim in which:
(1) an abbreviated new drug (generic) application filer receives anything of value; and
(2) such filer agrees not to research, develop, manufacture, market or sell the generic drug. Excludes a resolution or settlement that includes no more than:
(1) the right to market the generic drug before the expiration of the patent or other exclusivity period; or
(2) the waiver of a patent infringement claim for damages. Authorizes the Federal Trade Commission (FTC) to exempt agreements in furtherance of market competition and for the benefit of consumers. Amends the Federal Food, Drug, and Cosmetic Act to provide that a generic drug applicant forfeits market exclusivity for failing to market the drug 75 days after:
(1) a court dismisses a declaratory judgment action for lack of subject matter jurisdiction; or
(2) the applicant files with the Secretary of Health and Human Services a covenant that the patent owner will not sue the applicant for patent infringement. Deems an applicant to have forfeited market exclusivity if the applicant enters into an agreement that violates this Act. Amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to revise reporting requirements related to agreements between a generic drug applicant and a brand name drug company to include:
(1) a description of the subject matter of other agreements between the parties; and
(2) a certification that the materials filed represent the complete, final, and exclusive agreement between the parties.
...Read the Rest
Recent News Coverage
FTC And DOJ Issue Joint Report Regarding Antitrust Enforcement And ...
... though no law has yet been passed. See Senate Bill 316, entitled the "Preserve Access to Affordable Generics Act;" HR 1432; and HR 1902.
Letter: Repeal tax on Social Security benefits
... and all Americans to slip by -- support the Liberty Committee and Congressman Ron Paul’s HR 1902, the Social Security benefits tax reduction act, ...
Recent Blog Coverage
View All (38)
|
View Top Rated
H.R.1902: Minority Business Development ... - OpenCongress
A bill in the U.S. Congress: To establish in the Department of Commerce the Minority Business Development Program to provide qualified minority businesses with technical assistance and contracting opportunities, ... - ...
Religious Action Center :: RACBlog: Looking Forward: WRJ in the ...
Healthy Families Act (H.R.1902, S.932, and S.1085) provides workers with paid sick leave; Fair Pay Restoration Act (S. 1843) which, like its House-passed companion bill, eliminates the statute of limitations on seeking redress for pay ...
Panel Discusses the Future of Employment Law at Business Policy ...
1843), the Healthy Families Act (HR 1902/S. 1085), and others. Listen to VanDeusen discuss what happened in the last Maryland General Assembly Session and the future of legislation passed. ...

U.S. Congress - H.R.1902 Protecting Consumer Access to Generic Drugs Act of 2007



